| Literature DB >> 30995217 |
Graeme Benstead-Hume1, Xiangrong Chen1, Suzanna R Hopkins2, Karen A Lane2, Jessica A Downs2, Frances M G Pearl1.
Abstract
In response to a need for improved treatments, a number of promising novel targeted cancer therapies are being developed that exploit human synthetic lethal interactions. This is facilitating personalised medicine strategies in cancers where specific tumour suppressors have become inactivated. Mainly due to the constraints of the experimental procedures, relatively few human synthetic lethal interactions have been identified. Here we describe SLant (Synthetic Lethal analysis via Network topology), a computational systems approach to predicting human synthetic lethal interactions that works by identifying and exploiting conserved patterns in protein interaction network topology both within and across species. SLant out-performs previous attempts to classify human SSL interactions and experimental validation of the models predictions suggests it may provide useful guidance for future SSL screenings and ultimately aid targeted cancer therapy development.Entities:
Mesh:
Substances:
Year: 2019 PMID: 30995217 PMCID: PMC6488098 DOI: 10.1371/journal.pcbi.1006888
Source DB: PubMed Journal: PLoS Comput Biol ISSN: 1553-734X Impact factor: 4.475
Fig 1A schematic visualising how SLant’s source data is collated from STRING and the Gene Ontology Consortium, preprocessed so that this source data can be directed joined with BioGRID data for labeling and processed to create the final training set.
Feature generation was completed using R, the R igraph library and GoSemSim, a Bioconductor package.
Names and descriptions of the node-wise and pairwise network parameters and GO term features used in Slant.
| Name | Class | Description |
|---|---|---|
| Betweenness | Node-wise | The number of shortest paths in the entire graph that pass through the node. |
| Constraint | Node-wise | Related to ego networks. A measure of how much a node’s connections are focused on single cluster of neighbours. |
| Closeness | Node-wise | The number of steps required to reach all other nodes from a given node. |
| Coreness | Node-wise | Whether a node is part of the k-core of the full graph, the k-core being a maximal sub-graph in which each node has at least degree k. |
| Degree | Node-wise | The number of edges coming in to or out of the node. |
| Eccentricity | Node-wise | The shortest path distance from the node farthest from the given node. |
| Eigen centrality | Node-wise | A measure of how well connected a given node is to other well-connected nodes. |
| Hub score | Node-wise | Related to the concepts of hubs and authorities the hub score is a measure of how many well linked hubs the nodes is linked to. |
| Neighbourhood n size | Node-wise | The number of nodes within n steps of a given node for n of 1, 2, 5 and 6 |
| Adhesion | Pairwise | The minimum number of edges that would have to be severed to result in two separate sub-graphs separating the source and target nodes. |
| Cohesion | Pairwise | The minimum number of nodes that would have to be removed to result in two separate sub-graphs separating the source and target nodes. |
| Adjacent | Pairwise | Whether a source and target node are connected via an edge. |
| Mutual neighbours | Pairwise | How many first neighbours a target and source node share. |
| Shortest path | Pairwise | The minimal number of connected vertices that create a path between the source and target node. |
| Between community | Pairwise | A logical feature stating whether the source and target nodes inhabit the same community produced by the spin glass random walk. |
| Cross community | Pairwise | A logical feature stating whether the source and target nodes connect two communities as produced by the spin glass random walk. |
| Shared GO count–Biological process | Go term | The number of biological process GO annotations shared between the source and target node. |
| Shared GO count–Molecular function | Go term | The number of molecular function GO annotations shared between the source and target node. |
| Shared GO count–Cellular compartment | Go term | The number of cellular compartment GO annotations shared between the source and target node. |
Fig 2A set of violin plots illustrating the value distributions for each feature in our human training set grouped into SSL and non-SSL classes.
The features were derived from 411 SSL and 411 non-SSL gene pairs (see S6 Table). Feature distributions that show greater variance between SSL and non-SSL gene pair classes, for example the shortest path feature, often provide improved predictive power in classifiers.
Fig 3a. Human protein-protein interaction network with clustered communities generated by a spin glass random walk. Nodes and edges are coloured by their source community cluster as per the legend provided in Fig 3B. b. Community cluster connection graph where the weight of each connection corresponds to how many SSL interacting pairs begin and end at each community. We observe the largest count of SSL interactions occurring between cluster 9, notably associated with transcription regulation and DNA damage response GO terms and cluster 15, associated with MAPK cascade, cell proliferation and gene expression GO terms.
Cross validation ROC AUC scores for each organism from both in-species and cross species SSL models.
The best score for each species model is highlighted in green. Models are displayed vertically in rows with the consensus model displayed at the bottom of the table and the results for those models are displayed in columns with the consensus results highlighted in blue.
| Validation results | ||||||
|---|---|---|---|---|---|---|
| H. | S. | C. | D. | S. | ||
| H. sapiens | 0.965 | 0.698 | 0.662 | 0.687 | 0.661 | |
| S. cerevisiae | 0.713 | 0.883 | 0.694 | 0.784 | 0.717 | |
| C. elegans | 0.769 | 0.598 | 0.979 | 0.744 | 0.588 | |
| D. melanogaster | 0.727 | 0.790 | 0.816 | 0.906 | 0.778 | |
| S. pombe | 0.48 | 0.607 | 0.574 | 0.660 | 0.889 | |
| Consensus | 0.985 | 0.907 | 0.982 | 0.903 | 0.920 | |
Fig 4Cross-species ROC AUC scores for each models classification performance on our human SSL interaction validation set.
An additional curve for our consensus predictions was added separately based on the performance of the consensus validation set.
Fig 5Carcinogenic survival assay results charting survival of PBRM1 / BAF180 knock-out cell lines with concentration intervals of the PARP inhibitor Olaparib, the POLA inhibitor Erocalciferol and the ABL inhibitor Dasatanib.
These results suggest PBRM1 mutant cells may be more sensitive to both the PARP and ABL1 inhibitors while gaining some resistance to POLA1 inhibition. Error bars measure standard error of measurement. All drug intervals are measured in mM.